Financial results - SYNCO DEAL PHARMACEUTICALS SRL

Financial Summary - Synco Deal Pharmaceuticals Srl
Unique identification code: 24177540
Registration number: J2013002272238
Nace: 4773
Sales - Ron
1.147.519
Net Profit - Ron
14.800
Employees
3
Open Account
Company Synco Deal Pharmaceuticals Srl with Fiscal Code 24177540 recorded a turnover of 2024 of 1.147.519, with a net profit of 14.800 and having an average number of employees of 3. The company operates in the field of Comerţ cu amănuntul al produselor farmaceutice having the NACE code 4773.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Synco Deal Pharmaceuticals Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 139.650 211.830 169.413 247.488 236.440 655.646 409.090 198.641 643.504 1.147.519
Total Income - EUR 142.087 213.278 169.414 247.488 236.440 655.649 409.285 198.765 657.615 1.147.533
Total Expenses - EUR 135.016 212.399 140.430 207.712 191.664 547.165 421.002 166.623 664.613 1.132.733
Gross Profit/Loss - EUR 7.071 878 28.984 39.776 44.777 108.484 -11.717 32.143 -6.998 14.800
Net Profit/Loss - EUR 5.675 674 27.946 37.301 42.412 105.227 -16.394 30.718 -11.100 14.800
Employees 5 4 3 3 2 3 3 4 4 3
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 79.3%, from 643.504 euro in the year 2023, to 1.147.519 euro in 2024. The Net Profit increased by 14.800 euro, from 0 euro in 2023, to 14.800 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Synco Deal Pharmaceuticals Srl

Rating financiar

Financial Rating -
SYNCO DEAL PHARMACEUTICALS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Synco Deal Pharmaceuticals Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Synco Deal Pharmaceuticals Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Synco Deal Pharmaceuticals Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Synco Deal Pharmaceuticals Srl - CUI 24177540

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 3.309 2.632 3.360 2.898 2.594 5.162 22.812 126.349 170.071 46.584
Current Assets 681.016 701.619 617.814 439.768 211.904 379.553 396.891 634.479 571.456 925.883
Inventories 389.116 395.269 420.325 272.451 157.620 213.061 182.960 358.046 310.875 403.424
Receivables 177.470 209.527 182.665 159.945 46.664 92.450 192.082 259.189 341.761 545.004
Cash 114.430 96.823 14.823 7.372 7.620 74.042 21.848 17.245 -81.180 -22.544
Shareholders Funds 37.782 38.071 65.340 101.327 141.777 244.197 222.387 253.796 159.713 173.620
Social Capital 11.249 11.134 10.945 10.745 10.537 10.337 10.108 10.139 10.108 10.052
Debts 646.543 666.180 555.834 341.340 72.721 140.518 216.185 526.408 628.896 799.352
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 925.883 euro in 2024 which includes Inventories of 403.424 euro, Receivables of 545.004 euro and cash availability of -22.544 euro.
The company's Equity was valued at 173.620 euro, while total Liabilities amounted to 799.352 euro. Equity increased by 14.800 euro, from 159.713 euro in 2023, to 173.620 in 2024.

Risk Reports Prices

Reviews - Synco Deal Pharmaceuticals Srl

Comments - Synco Deal Pharmaceuticals Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.